Inactive Instrument

News Wise Oakwood Ventures Inc Toronto S.E.

Equities

WOWp

CA9772561069

End-of-day quote Toronto S.E. Other stock markets
-	-

Apr. 01	Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 01	Zomedica Seeks Acquisitions	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024	Apr. 10	AQ
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Zomedica Seeks Acquisitions	Apr. 01	CI
Transcript : Zomedica Corp., Q4 2023 Earnings Call, Apr 01, 2024	Apr. 01
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M	Apr. 01	MT
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024	Apr. 01	CI
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform	Mar. 15	AQ
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform	Mar. 14	CI
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences	Mar. 13	AQ
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs	Mar. 08	AQ
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024	Mar. 06	AQ
Transcript : Zomedica Corp. - Shareholder/Analyst Call	Feb. 28
Transcript : Zomedica Corp. - Analyst/Investor Day	Feb. 13
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences	Feb. 09	AQ
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET	Feb. 07	AQ
Open Letter to Zomedica Shareholders from your Chief Executive Officer	Feb. 01	AQ
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference	Jan. 31	AQ
Zomedica Pharmaceuticals Reports Preliminary Q4 Revenue	Jan. 17	MT
Transcript : Zomedica Corp., 2023 Sales/ Trading Statement Call, Jan 17, 2024	Jan. 17
Zomedica Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024	Jan. 17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Wise Oakwood Ventures Inc Toronto S.E.

Equities

WOWp

CA9772561069

Summary

Filters